First Time Loading...

EyePoint Pharmaceuticals Inc
NASDAQ:EYPT

Watchlist Manager
EyePoint Pharmaceuticals Inc Logo
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Watchlist
Price: 12.45 USD 1.88% Market Closed
Updated: May 15, 2024

EyePoint Pharmaceuticals Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

EyePoint Pharmaceuticals Inc
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Gross Profit
$41.4m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Gross Profit
$59.6B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$34.6B
CAGR 3-Years
2%
CAGR 5-Years
16%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Gross Profit
$38.8B
CAGR 3-Years
55%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Merck & Co Inc
NYSE:MRK
Gross Profit
$46B
CAGR 3-Years
17%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$28.8B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
5%

See Also

What is EyePoint Pharmaceuticals Inc's Gross Profit?
Gross Profit
41.4m USD

Based on the financial report for Dec 31, 2023, EyePoint Pharmaceuticals Inc's Gross Profit amounts to 41.4m USD.

What is EyePoint Pharmaceuticals Inc's Gross Profit growth rate?
Gross Profit CAGR 3Y
13%

Over the last year, the Gross Profit growth was 25%. The average annual Gross Profit growth rates for EyePoint Pharmaceuticals Inc have been 13% over the past three years .